Submission Details
| 510(k) Number | K123563 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 19, 2012 |
| Decision Date | August 20, 2013 |
| Days to Decision | 274 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K123563 is an FDA 510(k) clearance for the LEADCARE (R) ULTRA (TM) BLOOD LEAD TESTING SYSTEM, a Lead, Atomic Absorption (Class II — Special Controls, product code DOF), submitted by Magellan Diagnostics (North Billerica, US). The FDA issued a Cleared decision on August 20, 2013, 274 days after receiving the submission on November 19, 2012. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3550.
| 510(k) Number | K123563 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 19, 2012 |
| Decision Date | August 20, 2013 |
| Days to Decision | 274 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DOF — Lead, Atomic Absorption |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3550 |